Apicidin Induces Apoptosis via Cytochrome c-Mediated Intrinsic Pathway in Human Ovarian Cancer Cells
![]() ![]() |
Ahn, Mee-Young
(College of Pharmacy, Pusan National University)
Na, Yong-Jin (Department of Obstertrics and Gynecology, College of Medicine, Pusan National University) Lee, Jae-Won (College of Pharmacy, Pusan National University) Lee, Byung-Mu (Division of Toxicology, College of Pharmacy, Sungkyunkwan University) Kim, Hyung-Sik (College of Pharmacy, Pusan National University) |
1 | Xu, W. S., Parmigiani, R. B., Marks, P. A. (2007). Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26, 5541-5552 DOI ScienceOn |
2 | Takai, N., Desmond, J. C., Kumagai, T., Gui, D., Said, J. W., Whittaker, S., Miyakawa, I. and Koeffler, H. P. (2004). Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. Clin. Cancer Res. 10, 1141-1149 DOI ScienceOn |
3 | Marks, P. A., Richon, V. M., Miller, T. and Kelly, W. K. (2004). Histone deacetylase inhibitors. Adv. Cancer Res. 91, 137-168 DOI ScienceOn |
4 | Schepper, S. D., Bruwiere, H. L. N., Verhulst, T., Steller, U., Andries, L., Woutesrs, W., Janicot, M., Artis, J., Heusden, J. V. (2003). Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of surviving. J. Pharm. Exp. Therap. 304, 881-888 DOI ScienceOn |
5 | Im, J. Y., Park, H., Kang, K. W., Choi, W. S. and Kim, H. S. (2008). Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells. Chem. Biol. Interact. 172, 235-244 DOI ScienceOn |
6 | Shao, Y., Gao, Z., Marks, P. A. and Jiang, X. (2004). Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 101, 18030-18035 DOI ScienceOn |
7 | Ahn, M. Y., Jung, J. H., Na, Y. J. and Kim, H. S. (2008). A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells. Gynecol. Oncol. 108, 27-33 DOI ScienceOn |
8 | American Cancer Society. Retrieved September 4, 2007, www.cancer.org |
9 | Baradari, V., Huether, A., Hopfner, M., Schuppan, D. and Scherübl, H. (2006). Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. Endocr. Relat. Cancer 13, 1237-1250 DOI ScienceOn |
10 | Bokelmann, I. and Mahlknecht, U. (2008). Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins. Mol. Med. 14, 20-27 |
11 | Ding, Z., Yang, X., Pater, A. and Tang, S. C. (2000). Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells. Biochem. Biophys. Res. Commun. 270, 415-420 DOI ScienceOn |
12 | Eastman, A. (2004). Cell cycle checkpoints and their impact on anticancer therapeutic strategies. J. Cell Biochem. 91, 223-231 DOI ScienceOn |
13 | Green, D. R. and Reed, J. C. (1998). Mitochondria and apoptosis. Science 281, 1309-1312 DOI ScienceOn |
14 | Han, J. W., Ahn, S. H., Park, S. H., Wang, S. Y., Bae, G. U., Seo, D. W., Kwon, H. K., Hong, S., Lee, H. Y., Lee, Y. W. and Lee, H. W. (2000). Apicidin, a Histone Deacetylase Inhibitor, Inhibits Proliferation of Tumor Cells via Induction of p21WAF1/Cip1 and Gelsolin. Cancer Res. 60, 6068-6074 |
15 | Kim, M. S., Son, M. W., Kim, W. B., Park, Y. I. and Moon, A. (2000). Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype. Cancer Lett. 157, 23-30 DOI ScienceOn |
16 | Kwon, S. H., Ahn, S. H., Kim, Y. K., Bae, G. U., Yoon, J. W., Hong, S., Lee, H. Y., Lee, Y. W., Lee, H. W. and Han, J. W. (2002). Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells. J. Biol. Chem. 277, 2073-2080 DOI ScienceOn |
17 | Liu, T., Kuljaca, S., Tee, A. and Marshall, G. M. (2006). Histone deacetylase inhibitors: Multi-functional anticancer agents. Cancer Treat. Rev. 32, 157-165 DOI ScienceOn |
18 | Mogal, A. and Abdulkadir, S. A. (2006). Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes. Mol. Cell. Probes 20, 81-86 DOI ScienceOn |
19 | Petrella, A., D'Acunto, C. W., Rodriquez, M., Festa, M., Tosco, A., Bruno, I., Terracciano, S., Taddei, M., Paloma, L. G. and Parente, L. (2008). Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1. Eur. J. Cancer 44, 740-749 DOI ScienceOn |
20 | Shankar, S. and Srivastava, R. K. (2008). Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis. Adv. Exp. Med. Biol. 615, 261-298 DOI |
21 | Sobola, H. D., Noymana, E. C., Kazanova, D., Figerb, A., Birkenfelda, S., Shapiroa, L. M., Benamouzig, R. and Arber, N. (2006). Celecoxib leads to G2/M arrest by induction of p21 and down-regulation of cyclin B1 expression in a p53-independent manner. Eur. J. Cancer 42, 422-426 DOI ScienceOn |
22 | Takai, N. and Narahara, H. (2007). Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis. Curr. Med. Chem. 14, 2548-2553 DOI ScienceOn |
23 | Toh, Y., Yamamoto, M., Endo, K., Ikeda, Y., Baba, H., Kohnoe, S., Yonemasu, H., Hachitanda, Y., Okamura, T. and Sugimachi, K. (2003). Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma. Oncol. Rep. 10, 333-338 |
24 | Ueda, T., Takai, N., Nishida, M., Nasu, K. and Narahara, H. (2007). Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells. Int. J. Mol. Med. 19, 301-308 |
25 | Wang, X. (2001). The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922-2933 |
26 | Cheong, J. W., Chong, S. Y., Kim, J. Y., Eom, J. I., Jeung, H. K., Maeng, H. Y., Lee, S. T. and Min, Y. H. (2003). Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Clin. Cancer Res. 9, 5018-5027 |
27 | Kim, T. Y., Bang, Y. J. and Robertson, K. D. (2006). Histone deacetylase inhibitors for cancer therapy. Epigenetics 1, 14-23 DOI ScienceOn |
28 | Naora, H. and Montell, D. J. (2005). Ovarian cancer metastasis: integrating insights from disparate model organisms. J. Nat. Rev. Cancer 5, 355-366 DOI ScienceOn |
![]() |